Qkine
Latest round
- Series A
Last raised
- Apr 2020
Total raised
- $2.8M
Investors
- 4
About Qkine
Qkine Ltd, founded in 2016 and headquartered in Cambridge, UK, focuses on manufacturing recombinant proteins essential for life sciences research. The company was established by Catherine Elton and Marko Hyvönen.Qkine specializes in the manufacturing of high-purity, animal-free recombinant proteins, including growth factors and cytokines vital for various life science applications. Their product line supports stem cell and organoid cultures, contributing to advancements in cellular agriculture, regenerative medicine, and bioprinting. Key offerings include FGF2-G3, a thermostable form of FGF-2, and other recombinant proteins like activin A and BDNF, ensuring consistent bioactivity essential for biological research.Qkine generates revenue primarily through direct sales to research institutions and life sciences companies on a B2B basis. Clients place bulk orders for specialized growth factors and cytokines tailored to specific research requirements, with comprehensive documentation for regulatory compliance. The company plans to develop new products tailored to life sciences applications and is targeting expansion into additional geographic markets. The funds will support the growth of research teams and further product development initiatives.
Who invested in Qkine
4 investors across 3 rounds
See all investors in Qkine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Qkine
Who invested in Qkine?
Qkine has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qkine raised?
Qkine has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Qkine last raise money?
Qkine's most recent round on record is a Series A, in Apr 2020.
What does Qkine do?
Qkine Ltd, founded in 2016 and headquartered in Cambridge, UK, focuses on manufacturing recombinant proteins essential for life sciences research.
Where is Qkine headquartered?
Qkine is headquartered in Cambridge, UK.
Which VCs invest in companies like Qkine?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Qkine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Qkine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.